Message from the Directors

The UPenn PRC is a catalyst for research in chronic disease prevention and a leader in advancing the science and practice of prevention research. Along with our ongoing studies in cancer prevention, cognitive health, and new strategies for weight loss, we’re researching adolescent and young adult survivors of childhood cancers, the economic impact of clinical trials, and a Penn-community partnership, the Philadelphia Health Leadership Institute.  We invite you to learn more about these projects and our dedicated investigators and staff on this website.

– Karen Glanz & Kevin Volpp

Upcoming Events

Q & A Spotlight

  • Why is Prostate-Specific Antigen(PSA) testing controversial?
    Until recently, annual PSA testing for men beginning at age 50 was a standard recommendation.  As more is learned that potential harms may outweigh benefits, many doctors & organizations caution against routine screening.  In 2012, the US Preventive Services Task Force recommended against routine PSAs.  Some feel the new recommendation may lower risk of false alarms and potential complications in unnecessary treatment.  Others fear the new recommendation may lead to higher mortality rates if tumors go undetected and prostate cancer undiagnosed until too late.